Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy
    Meeting Abstract

    Sadelain, M.; Condomines, M.; Zhao, Z.; Brentjens, R. J.; Riviere, I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease
    Journal Article

    Zingone, A.; Wang, W.; Corrigan-Cummins, M.; Wu, S. P.; Plyler, R.; Korde, N.; Kwok, M.; Manasanch, E. E.; Tageja, N.; Bhutani, M.; more...
    Cytokine (2014)

    Fulltext@MSK | Save
  • Investigations into the tumor specific regulation of HER2 by Grp94 in breast cancer
    Meeting Abstract

    Yan, P.; Patel, H.; Yang, C.; Taldone, T.; Chiosis, G.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Sadelain, M.; Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Role of PRKD2 in HSP90 inhibition-mediated suppression of cancer growth
    Meeting Abstract

    Azoitei, N.; Diepold, K.; Genze, F.; Rouhi, A.; Brobovich, S.; Froehling, S.; Chiosis, G.; Brunner, C.; Van Lint, J.; Cronauer, M.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • The riboproteome orchestrates self-renewal and cell fate in leukemia
    Book Section

    Amin, E. M.; Kharas, M. G.
    In Vinagolu, R. (Eds.) Cancer Stem Cells (2014)

    Fulltext@MSK | Save
  • Interim analysis of a randomized phase II trial comparing continuous lenalidomide and dexamethasone to autologous stem cell transplantation in multiple myeloma patients responsive to lenalidomide and dexamethasone induction
    Meeting Abstract

    Weltz, J. I.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; Devlin, S. M.; Riedel, E.; Woo, K. M.; Stellman, A.; Chimento, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Glutamine based pet imaging facilitates enhanced metabolic fetection of gliomas in vivo
    Meeting Abstract

    Venneti, S.; Dunphy, M.; Zhang, H. W.; Pitter, K.; Campos, C.; Carlin, S.; Lyashchenko, S.; Ploessl, C.; Rohle, D.; Omuro, A.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save